FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq futures fall 1% as AI rout deepens on debt concerns
- Oil prices slips as US weighs easing sanctions on 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Walmart stock: Deutsche Bank gets bullish amid pricing tailwinds
- U.S. consumer prices rise by 3.7% year-on-year in September
Protara completes enrollment in THRIVE-3 Phase 2b trial
Tweet Send to a Friend
Protara Therapeutics, Inc. (Nasdaq: TARA) announced it has completed enrollment of the Phase 2b, open-label dose confirmation phase of its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
